Oncofertility cases (30%), |
• 16.5 y.o. with Hodgkin’s disease. planned to receive 2.5 gr of cyclophosphamide. Oncologist against FP. Should we offer FP? |
• 28 y.o. single male. Stage IV Hodgkin’s disease with superior vena cava syndrome. Very few immotile sperm cell in ejaculate. Should we attain testicular sperm? |
Potential gonadotoxic damage of various medical treatments (23%) |
• Is FP indicated in a patient with carcinoma of thyroid prior to radiotherapy? |
• 23 y.o. stage IV clear cell carcinoma of kidney, planned to receive Lenvatinib plus Pembrolizumab. Should we offer FP? |
Women and girls with POI (16%) |
• 14 y.o. family history of POI (mother & aunt), AMH 0.6, no genetic diagnosis. Should we offer FP? |
• 12.5 y.o.Turner mosaicism, low ovarian reserve markers. What to do? |
Ovarian tissue cryopreservation (9%) |
• how long can we keep ovarian tissue in media prior to freezing? |